Atlas Trials

Michael Hopp

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Michael Hopp

RecordFirmDate
Efficacy and Safety of Standard of Care Plus Durvalumab in Patients With Limited Disease Small Cell Lung Cancer (DOLPHIN) (NCT04602533)Michael Hopp2020-12-21
AFAMOSI: Efficacy and Safety of Afatinib Followed by Osimertinib Compared to Osimertinib in Patients with EGFRmutated/T790M Mutation Negative Nonsquamous NSCLC (NCT04413201)Michael Hopp2020-09-11

Track Michael Hopp automatically

Every clearance here is in the API, with alerts when new ones post.